Previous studies suggest that p56 lck activity influences thymocyte development at a stage prior to TCR αβ expression. Transgenic mice that express high levels of p56 lck activity during thymopoiesis develop thymic lymphomas consisting of cells with immature surface phenotypes. We have utilized cell lines derived from lck-induced thymic tumors to define biochemical pathways regulated by p56 lck activity in immature thymocytes. Here we report that components of the Ras/Raf/MAPK pathway are constitutively activated in these lck-transformed immature thymoblasts. p56 lck utilizes Shc and Grb2 adaptors to mediate activation of p21 ras in the thymoblast lines by promoting tyrosine phosphorylation of the Shc protein and constitutive interaction between Shc and Grb2. The putative guanine nucleotide exchange factor p95 vav is also maintained in constitutively tyrosine phosphorylated form as a result of elevated Lck activity. One target of activated Ras, the Raf-1 kinase, is hyperphosphorylated and downstream targets of activated Raf-1, Erk1 and Erk2, are hyperphosphorylated and activated in Lck-transformed thymocytes. Forskolin treatment reverses Raf-1 hyperphosphorylation in the cells and inhibits proliferation by blocking G 1 /S transition. In contrast, conventional protein tyrosine kinase inhibitors block proliferation by arresting Lck thymoblasts at G 2 /M. Lck-mediated stimulation of the Ras/Raf/MAPK pathway is also required to maintain cell viability by preventing programmed cell death. In summary, p56 lck activity stimulates G 1 /S transition in immature thymoblasts and maintains cell viability via transduction of constitutive activation signals downstream to components of the Ras/Raf/MAPK pathway.
Introduction
Signal transduction in T lymphocytes is influenced by expression irrespective of co-receptor expression (8) (9) (10) . In addition, p56 lck has been shown to associate with the β chain membrane-associated protein tyrosine kinases (PTK) (1) . Accumulating data indicate that p56 lck , a member of the of the IL-2R and becomes activated following IL-2 treatment of normal T cells (11, 12) . src-related, non-receptor type PTK, is involved in signaling pathways that regulate lymphocyte activation. p56 lck physic-
The notion that p56 lck influences thymocyte development in stages preceding TCR αβ expression has been supported ally associates with the CD4 and CD8 co-receptor structures on T lymphocytes and becomes activated when CD4 is crossby several lines of evidence. p56 lck is expressed in all T lineage cells including NK cells, with lck transcripts accumulating to linked (2) (3) (4) (5) . Co-receptor regulated activation of p56 lck may serve to optimize TCR signaling, as alterations in CD4 or CD8 highest levels in immature thymocytes (13, 14) . Mice rendered p56 lck deficient following either targeted disruption of the lck that affect interaction with p56 lck compromise activation in some antigen-specific T cell lines (6, 7) . Biochemical and gene (15) or overexpression of a dominant-negative form of p56 lck (16) display a severe block in thymocyte maturation genetic evidence also suggest that in addition to mediating co-receptor function, p56 lck may transduce signals directly prior to TCR αβ ϩ development. In their inability to generate double-positive (DP) cells, lck-deficient mice closely resemble from the TCR-CD3 complex. Thus, p56 lck is capable of directly interacting with the ζ chain of the TCR complex and TCRanimals exhibiting defects associated with loss of signaling via the TCR β chain, such as strains bearing homozygous CD3-mediated signaling is diminished in cells lacking lck RAG-1, RAG-2, or TCR β and disruptions (17) (18) (19) (20) . Similarly, types and for differentiation in other cell types (35). Our results indicate that overexpression of p56 lck in developing many aspects of thymocyte development in the presence of high levels of Lck activity resemble developmental abnormalitthymocytes activates components of the Ras/Raf/MAPK pathway, and, further, that activation of this pathway is required ies induced by TCR β transgene expression, such as the inhibition of V β D β but not D β J β or V α J α rearrangements, and to maintain cell viability and lck-induced proliferation of these cells. inefficient generation of DP cells (21, 22) . Thymic expression of activated p56 lck also mimics the effects of TCR β transgene expression or antibody-mediated cross-linking of CD3ε in Methods RAG-null animals, thus promoting reconstitution of thymus cellularity and maturation of DP cells (23-28). These observaReagents and antibodies tions have provided support for the hypothesis that p56 lck Genistein, aminogenistein, forskolin and propidium iodide participates in a signaling cascade from a pre-TCR complex were purchased from Calbiochem (La Jolla, CA). [ 3 H]Thymidconsisting of the TCR β chain, CD3 proteins and the recently ine and [γ-32 P]ATP were from Amersham (Arlington Heights, described disulfide-linked partner of the β chain, pTα (29,30). IL). Polyclonal antibodies against Shc, Erk2 (C-14), Raf-1 That expression of high levels of p56 lck protein in transgenic (C-12) and Vav (C14), and monoclonal anti-Lck antibody were mice promotes thymic lymphoma formation further suggests purchased from Santa Cruz Biotechnology (Santa Cruz, CA). that overexpression of p56 lck initiates a developmental Anti-phosphotyrosine mAb 4G10, and polyclonal anti-human program normally associated with β chain expression: allelic Lck kinase CT and NT antibodies were purchased from exclusion, expansion and maturation of immature thymoUpstate Biotechnology (Lake placid, NY). Anti-Grb2 mAb was cytes (31) .
purchased from Transduction Laboratories (Lexington, KY) How p56 lck -derived signals regulate aspects of cell replicaand rabbit anti-murine Lck Ab (195.7) was kindly provided tion and allelic exclusion in immature thymoblasts remains by Dr R. Perlmutter. largely unknown. Investigations of the downstream biochemical events precipitated by p56 lck activation have in Cell lines and culture most cases been conducted in T cell lines following cross-
The 6871 and 8979 cell lines were derived from independent linking of surface receptors including the TCR, the CD3 thymic lymphomas that arose in transgenic progeny of LGY complex, the co-receptors CD4 and CD8, and the IL-2R. 4220 and 7233 founders overexpressing wild-type p56 lck (21; Although these approaches point to the importance of p56 lck K. Abraham and R. Perlmutter, unpublished data). The 2047 in T cell activation, the analysis is often complicated by and 2293 cell lines were derived from thymic lymphomas in activation of multiple PTKs during stimulation. Moreover, animals overexpressing a mutant form of p56 lck bearing a p56 lck 's capacity to influence thymocyte development appears tyrosine to phenylalanine substitution at position 505 (LGF unrelated to its interaction with CD4 or CD8 co-receptors founder line 1127; 21). The 180 and 186 cell lines were (32). Nonetheless, the existence of a pre-TCR complex on adapted from independent thymic lymphomas of transgenic immature thymocytes that is influenced by p56 lck activity animal founders overexpressing SV40 large T antigen (36). suggests that some conservation may exist between downAll cell lines were cultured in RPMI 1640 supplemented with stream signaling initiated via the pre-TCR and the TCR αβ.
10% FCS, 50 nM β-mercaptoethanol, 1ϫnon-essential amino An examination of the signaling pathways regulated by p56 lck acids (Gibco/BRL, Gaithersburg, MD), 1 mM L-glutamine and in immature thymocytes will likely provide insights into the 5 µg/ml gentamycin. nature of p56 lck -mediated signal transduction during thymocyte development, which may in turn aid in elucidating the Cell proliferation assay role of p56 lck in signaling in mature T cells.
Cells were plated at 10 5 /ml in the presence of indicated Cell lines derived from thymic lymphomas formed in transconcentrations of inhibitors and pulsed for the final 6 h of genic animals expressing the wild-type (LGY) or activated culture with 1 µCi/well [ 3 H]thymidine (Amersham, Arlington form of p56 lck (LGF) provide an advantageous system for Heights, IL). Cultures were harvested onto glass fiber filter studying signaling pathways stimulated by p56 lck activity mats and processed for liquid scintillation counting. during early thymopoiesis (31) . Cell lines adapted to in vitro growth from these tumors consist of cells bearing CD3 -CD4 -Flow cytometric analysis CD8 -or CD3 -CD4 -CD8 lo phenotypes, resembling thymocytes in double-negative (DN) to DP transition. Presumably, the Thymi were dispersed into single-cell suspensions or thymoblast cell lines were washed once with HBSS and subsequently ability of p56 lck to promote cell replication during this developmental window contributes to thymocyte transformation.
stained for flow cytometric analysis as previously described (21, 36) . Reagents used in the analysis included the following Existing evidence suggests that both proliferative expansion and differentiation are regulated by pre-TCR engagement phycoerythrin-conjugated antibodies: anti-CD4 (CT-CD4; Caltag, South San Francisco, CA), anti-CD11b (M1/70.15; in immature thymocytes (33, 34) . Thus, by characterizing signaling pathways activated in cells immortalized during DN Caltag), anti-Thy-1.2 (30-H12; Gibco/BRL), anti-CD44 (IM7.8.1; Caltag), anti-CD25 (PC61 5.3; Caltag), anti-CD8β to DP transition as a direct result of elevated p56 lck activity, we hope to elucidate the mechanisms by which Lck may (CT-CD8β; Caltag) and anti-B220 (RA3-6B2; PharMingen, San Diego, CA). Biotinylated antibodies included: anti-CD3 exert these differing effects. In this report we have focussed on components of the Ras/Raf/MAPK pathway, which is (500.A2; Caltag), anti-CD5 (CG16; Caltag), anti-CD28 (37.51.1; Caltag), anti-CD69 (H1.2F3; PharMingen) and antirequired for growth-factor-stimulated replication in some cell p56 lck -dependent immortalization of immature thymocytes 293 CD117 (3C1; Caltag). Additional reagents included FITCLiCl, 0.1 M Tris, p H7.5, and once in Assay Dilution Buffer (AD B ) (20 mM MOPS, pH 7.2, 25 mM β-glycerol phosphate, conjugated anti-CD8α (CT-CD8α; Caltag) and anti-CD43 (S7; PharMingen), unconjugated anti-TER-119 (TER-119; Phar-5 mM EGTA, 1 mM sodium vanadate, 1 mM dithiothreitol). Kinase reactions were conducted using a MAP Kinase Assay Mingen) and anti-GR-1 (RB6-8C5; PharMingen). Binding of biotinylated antibodies was detected using streptavidinKit (Upstate Biotechnology) in a final volume of 40 µl AD B containing 10 µl of washed immune complex, 0.5 mg/ml MBP, TriColor conjugate (Caltag), detection of TER-119 and GR-1 was facilitated using monoclonal anti-rat IgG2b-FITC (G15-16.875 mM MgCl 2 , 112.5 µM ATP, 10 µCi [γ-32 P]ATP (~3000 Ci/mmol), 5 µM PKC inhibitor peptide, 0.5 µM PKA inhibitor 337; PharMingen). Each analysis was performed on 20,000 events acquired in list mode using a FACSort flow cytometer peptide and 5 µM compound R24571. After 10 min at 30°C, 25 µl of the reaction mixture was spotted onto p81 phospho-(Becton Dickinson, Mountain View, CA) equipped with Lysys II software. cellulose paper, washed with 0.75% phosphoric acid and acetone, and counted in a scintillation counter. The remaining RNA and DNA blot analysis reaction mixture was boiled in 1ϫSDS sample buffer and subjected to 12% SDS-PAGE, transferred to nitrocellulose, For Northern blot analysis, total RNA was isolated from cell pellets or mouse thymi using TRIzol Reagent (Life Technoloand exposed to X-ray film. The blot was then probed with the anti-Erk2 antibody (Santa Cruz) to verify the position and gies, Gaithersburg, MD). RNA (15 µg) was resolved on 1.5% formaldehyde gels, transferred to nylon membrane, quantity of p42 erk2 . The extent of activation in immune complexes was calculated following subtraction of background hybridized and washed according to standard procedures (37) . For Southern blot analysis, genomic DNA was isolated 32 P incorporation in the presence of RIPA buffer alone. by lysing cells in 100 mM Tris, pH 8.5, 5 mM EDTA, 0.2% DNA fragmentation assay SDS, 200 mM NaCl, 100 µg/ml proteinase K and precipitating DNA with isopropanol as described by Laird et al. (38) . DNA Cells (2ϫ10 6 ) were lysed in 1 ml lysis buffer (10 mM Tris, pH (10 µg) was digested to completion with HindIII, separated 7.5, 1 mM EDTA and 0.2% Triton-X 100). Samples were in 0.7% agarose gels, transferred, hybridized and washed subjected to centrifugation and supernatant containing low according to standard procedures (37) . Plasmid inserts mol. wt DNA was collected and precipitated overnight at specific for C β (39) or C α (40), or PCR amplified EF1α cDNA -20°C in 50% isopropanol and 0.5 M NaCl. The precipitate fragment (22) were labeled to high specific activity by random was collected by centrifugation at 13,000 r.p.m. for 10 min, priming (41; Amersham).
air-dried and resuspended in 10 mM Tris and 1 mM EDTA, pH 7.5. A loading buffer containing 15 mM EDTA, 2% SDS, Western blotting and immunoprecipitation 50% glycerol and 0.05% bromophenol blue was added at Cells were lysed in modified RIPA buffer (50 mM Tris, pH 7.4, 1:5 (v/v), samples were heated at 65°C for 10 min and 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM subjected to electrophoresis in TBE buffer in a 1% agarose EGTA, 1 mM phenylmethylsulfonyl fluoride, 1 µg/ml aprotinin gel containing 0.5 µg/ml ethidium bromide and visualized and leupeptin, 1 mM NaF and 1 mM Na 3 VO 4 ). Samples were under UV light. gently rocked on ice for 30 min and centrifuged at 12, 000 Cell cycle analysis r.p.m. for 10 min at 4°C. Total protein concentration was determined using a modified Lowry assay (BioRad DC Protein Cells (0.5-1ϫ10 6 ) were washed twice with 1ϫPBS, fixed on Assay Kit, Melville, NY). For immunoprecipitations, between ice for 1 h in 1ϫPBS containing 0.06% paraformaldehyde 500 µg and 1 mg of lysates was incubated with appropriate and collected by centrifugation at 500 g for 5 min at room antibodies for 1 h at 4°C, followed by incubation with Protein temperature. The cells were then permeablized in 1ϫPBS A-Sepharose beads (Pharmacia Biotech, Piscataway, NJ) containing 0.5% Tween 20 for 15 min at 37°C. A solution overnight at 4°C. Immunoprecipitates were washed three containing 5% FCS and 0.1% sodium azide in 1ϫPBS was times with RIPA buffer and boiled in 1ϫSDS sample buffer.
added and the cells were spun at 500 g for 5 min. The pelleted Total cell lysates or immunoprecipitates were separated by cells were resuspended in 1ϫPBS containing 50 µg/ml RNase, SDS-PAGE, transferred to nitrocellulose membrane and 0.1% sodium azide and 10 µg/ml propidium iodide, stained developed by enhanced chemiluminescence (Amersham).
overnight at 4°C, and analyzed by flow cytometry on a Becton Dickinson FACSort using Lysys II software for acquisition and Pervanadate treatment of cells CELLFIT software for analysis. Stock solutions of sodium orthovanadate and hydrogen peroxide were premixed for 15 min at room temperature and added Results to the cell culture medium at concentrations of 100 µM of sodium orthovanadate and 10 mM of hydrogen peroxide (43) .
Transgenic overexpression of Lck permits immortalization of The cells were then incubated for 2 min at 37°C before being immature thymocytes washed and lysed.
Thymic expression of transgenes directed by the lck proximal MAPK assay promoter is developmentally regulated, initiating in the most immature thymocyte subsets (CD3 -CD4 -CD8 -) and continuCells were lysed in RIPA buffer and 500 µg of total lysates were immunoprecipitated with 1 µg of anti-Erk2 antibody ing throughout subsequent stages of thymopoeisis (13, 43) . Transgenic overexpression of p56 lck using this promoter (Santa Cruz) as described above except that the pelleted beads were washed twice with RIPA buffer, twice with 0.5 M resulted in Lck-dependent immortalization of early thymocyte LGF-transformed cells have initiated rearrangements at the TCR β locus. In addition, the presence preferentially for outgrowth of CD3 -CD4 -CD8 -or CD3 -CD4 -CD8 lo thymoblasts. This adaptation is illustrated in Fig. 1 of transcripts encoding complete TCR β rearrangements indicates that either the immortalization event is not restricted which shows the progressive change in representation of cell subpopulations during the establishment of a LGY tumor cell to cells undergoing DJ joining or that immortalization does not prohibit further gene rearrangement at TCR β. line to in vitro growth. The primary tumor consists of a mixed population of CD3 -populations (primarily CD4 ϩ CD8 ϩ , CD8 lo Previous studies suggested that transgenic overexpression of the activated/mutant or wild-type forms of p56 lck produced and DN cells). The culture population changes over time and by 4 weeks in vitro the cell line is dominated by CD4 -CD8 -, qualitatively similar effects in vivo with differing efficiencies (21) . Accordingly, many characteristics of the 8979 LGY cell IL-2R -cells. Thus, although all cells populating the tumor overexpress p56 lck , cells bearing the most immature phenoline closely resemble the 2047 LGF cell line, including its oligoclonality at the level of TCR β rearrangement, its exprestypes are preferentially selected during in vitro outgrowth.
To define the stage of thymocyte development most sensitsion of both 1.0 and 1.3 kb TCR β mRNAs, and its expression of 1.6 kb TCR α mRNAs (Fig. 2B ). The second LGY line in ive to lck overexpression, a detailed characterization of a panel of lck-induced thymic lymphoma cell lines generated our analysis, 6871, resembles all lck thymoblasts in its Linstatus (TER-119 -, GR-1 -, CD11b -, B220 -; data not shown). as in Fig. 1 was performed using flow cytometry (Table 1) . Cell lines derived from animals overexpressing the activated However, 6871
LGY expresses a distinctive Thy-1 lo , CD117 ϩ , CD28 -phenotype ( Table 1 ). The complete loss of germline mutant form of lck, lckF505 (construct LGF, nos 2047 and 2293), exhibited characteristics consistent with immortaliz-C β 1 bands in 6871 suggests once again that immortalization took place following completion of DJ joining at both TCR β ation of a cell in the process of V-DJ joining at TCR β. Thus, in addition to lacking expression of CD3, CD4 and CD8, these alleles. Consistent with our findings in the other lck lines, the presence of high levels of Lck activity must not have comcells also lack expression of CD117 (c-kit), CD25 (the IL-2R α chain) and CD44. Multiple TCR β rearrangements are pletely prevented further rearrangement at TCR β in 6871, as TCR β mRNAs of both 1.0 and 1.3 kb can be readily detected. evident in genomic DNAs recovered from 2047 and 2293 cell lines ( Fig. 2A ). In addition, the complete loss of germline C β 1 However, mature TCR α mRNAs are not expressed in these cells (Fig. 2B) . Thus, expression of p56 lck activity at levels signal in 2293 and 2047 DNAs indicates that these lines consist of cells that have undergone rearrangements on both sufficient to promote transformation of immature thymocytes will not invariably block completion of rearrangements at TCR β alleles. The fact that 1.0 and 1.3 kb TCR β transcripts are expressed in 2293 and 2047 ( Fig. 2B ) further suggests TCR β. (Fig. 3A) . A proportion of the Lck protein present in the lck thymoblasts runs with retarded mobility in SDS-PAGE. The conversion of p56 lck to higher mol. wt forms has been observed following T cell activation and reflects the accumulation of Lck species bearing multiple N-terminal serine phosphorylations (44) (45) (46) . This constitutive modification of p56 lck is not routinely observed in either the SV40T antigen-transformed thymoblast lines or in normal thymocytes (Fig. 3A) , implying that the activity responsible is stimulated in response to the elevated lck expression in these cells.
The ability of p56 lck to stimulate tumor formation is dependent upon kinase activity (16) . As revealed in anti-phosphotyrosine specific immunoblots, a numerous and diverse set of proteins serve as substrates for the increased tyrosine kinase activity in the lck thymoblast lines (Fig. 3B) . The pattern of tyrosine phosphorylated proteins exhibited by the cell lines is comparable to phosphotyrosine patterns observed in primary tumors recovered directly from animals expressing LGF and LGY transgenes (21; K. Abraham and R. Perlmutter, unpub- lines, elevated lck expression stimulates conversion of p56 lck the link between p56 lck and p21 ras activation by examining proteins known to couple PTK activity to the Ras pathway in the lck thymoblasts. Recent reports indicate that a 36 kDa protein may mediate TCR-induced activation of p21 ras (49) . However, a protein of this size does not appear to be a primary substrate for tyrosine phosphorylation in the lck thymoblast lines (Fig. 3B and data not shown) . In contrast, at least one isoform of the Ras-adaptor protein Shc (p52 shc ) accumulates in a tyrosine phosphorylated form in the lck thymoblasts. Tyrosine phosphorylation of p52 shc is indicated both by the presence of p52 shc in anti-phosphotyrosine immunoprecipitates and by anti-phosphotyrosine immunoreactivity in anti-Shc immunoprecipitates ( Fig. 4A and B) . Whether p46 shc is also constitutively tyrosine phosphorylated in the lck thymoblasts could not be ascertained in this analysis, as the antibodies used in the immunoprecipitations interfered with p46 shc detection.
As expected, the 26 kDa Grb2 protein can be co-immunoprecipitated with Shc proteins only in lysates from the lck thymoblast lines (Fig. 4C ). This result likely reflects binding of the Grb2 SH2 domain to tyrosine phosphorylated Shc proteins. Interestingly, the LSTRA cell line which overexpresses p56 lck by 50-fold due to a retroviral insertion event in the lck locus (48) also contains tyrosine phosphorylated p52 shc . The association between phosphorylated Shc and Grb2 is also observed in LSTRA, although less Grb2 was coimmunoprecipitated with Shc from LSTRA than from the lck thymoblast lines (Fig. 4C) . Thus, immature thymocytes transformed by p56 lck resemble T cells activated via the IL-2R with respect to the presence of tyrosine phosphorylated Shc proteins and the resultant appearance of Shc-Grb2 complexes (47) .
Whether Shc can serve as a direct substrate for p56 lck in lymphocytes is unknown. However, the presence of p52 shc immunoreactivity in anti-p56 lck immunoprecipitates recovered from the lck thymoblasts argues that these two proteins may physically associate (Fig. 4D) . The fact that p52 shc -p56 lck complexes are not limited to the lck thymoblast lines, but can also be recovered from SV40T lines and normal thymocytes, nucleotide exchange (GNE) activity (50) (51) (52) . p95 vav becomes phosphorylated on tyrosine residues in response to TCR cross-linking, a modification that is correlated with augmented p95 vav GNE function (52, 53) . p95 vav can serve as an in vitro to slower migrating species and promotes constitutive tyrosine phosphorylation of multiple proteins.
substrate for p56 lck (52) , and a recent report documents a physical association between p95 vav and p56 lck in Jurkat cells Shc is constitutively phosphorylated and associated with Grb2 (53) . Our data are consistent with a role for p56 lck in stimulating in lck-transformed thymoblast lines p95 vav function, as tyrosine phosphorylated p95 vav accumulates only in thymoblasts overexpressing p56 lck (Fig. 5A and PTK and p21 ras activities are increased following stimulation of lymphocytes by the T cell antigen and IL-2R (47) . Although B). The identity of the 85 kDa protein observed as a crossreacting protein in our p95 vav analyses is unknown. Interesp56 lck has been reported to play a role in these events, simultaneous activation of multiple kinases by the TCR and tingly, this 85 kDa protein is also expressed in all thymic lymphoma cell lines and in normal thymocytes, and is constitu-IL-2R has made it difficult to assess the specific contribution of p56 lck activity to p21 ras activation. We have investigated tively tyrosine phosphorylated in the lck thymoblasts (Fig. 5B) . Figure 5 (B) also reveals the presence of abundant tyrosine recent activation of p56 lck in vivo, perhaps due to TCRdependent selection events. Unfortunately, whether the interphosphorylated proteins migrating at~50 kDa in anti-Vav immunoprecipitates recovered from the lck thymoblasts. At action between p56 lck and p95 vav in thymocytes is direct or indirect cannot be defined in these studies. However, based least one of these proteins is p56 lck , as demonstrated by immunoblotting of anti-Vav immunoprecipitates with monoon these observations we propose that p95 vav -p56 lck complex formation may be transiently stimulated in thymocytes by clonal anti-Lck antibody (Fig. 5C) . Similarly, p95 vav can be identified in Lck immunoprecipitates from 6871 and 8979 p56 lck activation, with dissociation of the complex following tyrosine phosphorylation of p95 vav by activated p56 lck .
LGY lines (Fig. 5D ). More Vav-Lck complexes exist in LGY thymoblast lines and normal thymocytes than in the LGF and Accordingly, when anti-Lck immunoprecipitates from 6871 LGY were probed with anti-phosphotyrosine mAb 4G10, no tyrosine SV40T lines, despite the elevated levels of p56 lck present in the LGF lines (Fig. 3A) and a similar extent of p95 vav tyrosine phosphorylated p95 could be detected (data not shown), suggesting that the majority of p95 vav present in the Vav-Lck phosphorylation in LGF and LGY lines (Fig 5B) . These observations suggest that constitutive association between p95 vav complexes may not be tyrosine phosphorylated. The fact that Vav-Lck complexes are not detectable in lck thymoblast lines and p56 lck in thymocytes may not require p95 vav tyrosine phosphorylation. In addition, although both the SV40T thymotransformed with the activated mutant form of Lck (p56 lck F505) may reflect a requirement for tyrosine 505 to promote the blasts and normal thymocytes possess unphosphorylated p95 vav , Vav-Lck complexes are more abundant in normal interaction. Alternatively, p56 lck F505 may phosphorylate p95 vav with rapid kinetics, promoting dissociation of the thymocytes. We speculate that this bias toward Vav-Lck complex formation observed in normal thymocytes may reflect complex in these cells. p74 raf-1 is hyperphosphorylated in lck thymoblast lines
The preceding results demonstrate that regulators of p21 ras activation are constitutively modified in lck-transformed thymoblasts. This observation led us to examine the status of the raf-1 proto-oncogene product, which has been shown to lie immediately downstream of p21 ras in the MAPK activation cascade in non-lymphoid cells (54, 55) . As shown in Fig. 6 , the 74 kDa Raf-1 protein present in lck thymoblasts migrates with retarded mobility in SDS-PAGE when compared to is constitutively hyperphosphorylated in the LGY and LGF thymoblasts. Since hyperphosphorylation of p74 raf-1 correlates with increased Raf-1 kinase activity (56, 57) , our data suggest that the Ras/Raf/MAPK pathway may be one of the signaling Activation of MAPK in lck thymoblast lines pathways stimulated by elevated p56 lck activity in these immature thymoblasts. Thus, the activity of the MAPK was Similar to the Raf-1 protein, activated p42 erk2 and p44 erk1 become hyperphosphorylated and exhibit reduced mobility subsequently examined. Kinase assays were performed in immunoprecipitates as described in Methods. An aliquot of 15 µl of the reaction mixture was separated on 12% SDS-PAGE, transferred to nitrocellulose and exposed to X-ray film (top). The blot was then probed with the anti-Erk2 antibody to determine the position and quantity of p42 erk2 (bottom). Positions of the 42 kDa Erk2 and the MBP are indicated. (C) Incorporation of 32 P into MBP in each Erk2 immune complex kinase reaction as determined by radioactivity (c.p.m.) retained on p81 phosphocellulose paper. The background activity obtained using immune complex recovered from RIPA buffer only was also determined. Error bars represent SD from three independent assays. in SDS-PAGE (58) . Mobility shifts indicative of p42 erk2 or As shown in Fig. 7 (B and C), MBP kinase activities were reproducibly stimulated to high levels only in the LGF lines. p44 erk1 activation in the lck thymoblasts could not be reliably demonstrated. However, as shown in Fig. 7(A) , shifts in p42
Quantification of the assay revealed that Erk2 activity is increased Ͼ20-fold in these cells relative to Erk2 activity in and p44 mobility became evident following treatment of the lck thymoblasts with pervanadate, a potent protein tyrosine SV40T lines or normal thymocytes. Surprisingly, both LGY lines (6871 and 8979) exhibited Ͻ2-fold stimulation of MBP phosphatase inhibitor (42) . We conclude that MAPK hyperphosphorylation is stimulated in lck-transformed thymoblasts.
kinase activity. The fact that pervanadate treatment is required to observe Increased intracellular cAMP blocks DNA synthesis and mobility shifts associated with MAPK phosphorylation suginduces programmed cell death (PCD) in lck thymoblast lines gests that endogenous phosphatases must effectively counterbalance the lck-stimulated hyperphosphorylation.
A number of recent reports have demonstrated that PKA can interfere with stimulation of the Ras/Raf/MEK/MAPK signaling A relatively high proportion of endogenous MAPK molecules must be activated to allow reliable detection of p42 and p44 pathway in living cells (59) (60) (61) (62) (63) (64) . The blockade occurs at the level of Raf-1 activation (59, 60, 62, 64) . To investigate whether mobility shifts. Thus, enzymatic assays were used to more definitively assess the steady state levels of endogenous activation of the MAPK pathway is required for maintenance of p56 lck -induced thymocyte transformation, we explored the MAPK activity in the cell lines. Kinase assays were performed using anti-Erk2 immune complexes recovered from various impact of PKA activation on the proliferation and viability of the thymoblast lines. The cell lines were treated with forskolin, cell types and myelin basic protein (MBP) as a substrate.
Agarose gel electrophoresis of DNA recovered from forskolin treated cells verified that forskolin induces DNA fragmentation characteristic of PCD in the lck thymoblasts as early as 6 h after treatment (Fig. 11 and data not shown) .
In contrast, although proliferation of the 180 cell line is moderately inhibited in the presence of forskolin, these cells do not undergo PCD following this treatment. Resistance of 180 SV40T to forskolin-induced PCD may reflect the ability of SV40T antigen to interfere with tumor suppressor gene function in these cells, as the p53 tumor suppressor gene product accumulates to supraphysiologic levels in both 180 SV40T src-PTK inhibition in these thymoblasts awaits the availability of more specific inhibitors of p56 lck function.
Treatment of the lck thymoblast lines with genistein also precipitates PCD, as evidenced by the emergence of an a drug that elevates cAMP levels via stimulation of adenylate cyclase activity (65) . The effect of forskolin treatment on apoptotic DNA peak in the cell-cycle analysis and by the DNA fragmentation profiles observed following agarose gel p74 raf-1 in our system was verified as shown in Fig. 8(A and  B) . Treatment of 6871 LGY cultures with 12 µM forskolin resulted electrophoresis of cellular DNA [Figs 10(A and B) and 11, and data not shown]. It is likely that the cells undergoing in conversion of hyperphosphorylated p74 raf-1 to a form with faster electrophoretic mobility, now co-migrating with p74 raf-1 genistein-induced apoptosis derive from cells that have accumulated in G 2 /M. This notion is supported by two findings: from the SV40T thymoblasts (Fig. 8A) . In addition, 12 µM forskolin treatment diminished MBP kinase activity in 2047 LGF G 2 /M arrest temporally precedes appearance of the apoptotic peak and the Ͻ2n peak proportionately increases as the thymoblasts by 63% as measured by the Erk2 immune complex kinase assay (Fig. 8B) number of cells in the G 2 /M population decreases. Again, the 180 cell line does not undergo apoptosis despite its apparently While all three cell lines tested (6871 LGY , 2047 LGF and 180 SV40T ) exhibit dose-dependent inhibition of [ 3 H]thymidine higher sensitivity to G 2 /M arrest. incorporation in the presence of forskolin, the lck thymoblast lines are more sensitive to this treatment in that their DNA Discussion synthesis is inhibited more rapidly and at lower concentrations of the drug (Fig. 9) . Cell-cycle analysis was performed using Previous studies demonstrated that overexpression of the lck gene, under the control of its own thymocyte-specific proximal flow cytometry to investigate the proliferative defect induced by forskolin treatment. Consistent with their rapid proliferative promoter, dramatically disturbed T cell development in transgenic mice (21) . In addition, transgenic lines expressing the rate, between 45 and 65% of cells recovered from untreated cultures are found in S and G 2 /M phases of the cell cycle (Fig. highest levels of p56 lck activity reproducibly developed thymic tumors populated by immature thymocytes (21, 31) . In this 10A). Forskolin treatment of the lck-transformed thymoblasts diminished progression into S phase, causing cells to accumureport we have utilized cell lines derived from lck-induced thymic tumors to characterize biochemical events underlying late in G 0 /G 1 . In addition, forskolin treatment induced PCD in the lck thymoblasts, as evidenced by the Ͻ2n DNA peak Lck-stimulated phenotypic defects in early thymocytes. We have shown that components of a pathway normally activated emerging in the DNA profile of treated cells (Fig. 10A and B) . in response to mitogenic signals, the Ras/Raf/MAPK pathway, primitive hematopoietic progenitor cells (Thy-1 lo , Lin -; 67,68). In contradiction to its surface staining profile, 6871 LGY does are stimulated in response to elevated p56 lck activity in these cells. In addition, with the aid of biochemical inhibitors it has not possess germline TCR β alleles. Moreover, 6871
LGY expresses mature 1.3 kb TCR β transcripts suggestive of V to been possible to demonstrate that constitutive activation of this lck-stimulated pathway is required to maintain cell viability DJ rearrangements. Although this apparent conflict between surface phenotype and TCR β rearrangement status may by inhibiting PCD.
Studies of transgenic mice bearing sub-tumorigenic levels reflect abnormalities associated with transformation, it is tempting to speculate that high levels of Lck activity may of p56 lck indicated that elevated p56 lck activity alters thymocyte development at a point prior to V β rearrangement but stimulate precocious D β -J β joining in hematopoietic progenitors. A rigorous examination of the relationship between Lck subsequent to D β -J β joining (22). In support of this notion, we find that rearrangements at the TCR β locus in the lck activity and TCR rearrangement in hematopoietic progenitors will require the recovery of these cells directly from LGY or LGF thymoblast lines are clonal or oligoclonal at the level of D β -J β joining. Interestingly, one of the lck-transformed thymoblast animals and an evaluation of their TCR rearrangement status. Thymi from lck-transgenic animals expressing p56 lck at cell lines, 6871 LGY , bears a surface phenotype similar to p56 lck -dependent immortalization of immature thymocytes 303 subtumorigenic levels contain few mature TCR β chain tranTriggering of the TCR-or the IL-2R-coupled PTK results in a rapid and prolonged accumulation of active p21 ras -GTP scripts due to a defect in V β to D β J β rearrangement (22). In contrast, all cell lines derived from lck tumors that were complexes (47) . p21 ras activation can be mediated by guanine nucleotide exchange factors (GNEF) such as the Sos gene examined express immature DJ (1.0 kb) and mature VDJ (1.3 kb) TCR β transcripts in equivalent amounts. Previous studies product (71 72). In fibroblasts, growth factor receptors utilize the adaptor protein Grb2/Sem5 to couple Sos to p21 ras . At also suggested that the differentiation block induced by heightened Lck activity follows D β rearrangement and that least two tyrosine phosphoproteins expressed by T cells are capable of interacting with the Grb2 SH2 domain: p46/ discrete V β rearrangements occur subsequently within individual cells (22). Our studies demonstrate that V β rearrange52Shc and p36 (49) . Both Shc and p36 become tyrosine phosphorylated following TCR-mediated activation; however, ments may proceed at some frequency even in cells expressing Lck activity at levels sufficient to promote and there appears to be preferential selection for p36 by Grb2, as only p36-Grb2 complexes accumulate in these cells maintain transformation. Further, as the cell lines are dominated by cells expressing equivalent levels of DJ and VDJ (47) . In contrast, in IL-2-activated cells there is no tyrosine phosphorylation of p36, rather there is a high level of Shc containing TCR β transcripts, it is likely that the lck thymoblast lines represent expansion of rare cells that have successfully tyrosine phosphorylation and rapid formation of Shc-Grb2-Sos complexes (73) . Our results indicate that Shc, not p36, initiated secondary rearrangements at TCR β following immortalization after D β -J β joining. Thus, we speculate that the is utilized by p56 lck for coupling Grb2-Sos in immature thymoblasts, in a scenario similar to that observed following presence of tumorigenic levels of Lck activity in rare progenitors undergoing V β to D β -J β joining may be sufficient to IL-2R engagement. In this respect, Shc phosphorylation in IL-2R-stimulated and possibly also in TCR-stimulated cells is simulate a pre-TCR engagement, thereby promoting entry into the cell cycle. Support for this hypothesis is provided by likely a consequence of p56 lck activation, whereas p36 may be a preferred substrate for other kinases such as ZAP-70, the examination of downstream effectors described in this report and in our unpublished data, which indicates that some which are activated by the TCR but not by the IL-2R (47).
The association between Shc and p56 lck in SV40 T antigencomponents of the pre-TCR complex are expressed in these cells (e.g. pTα; K. Lin and K. Abraham, unpublished results), transformed cell lines and in normal thymocytes suggests a scenario in which p56 lck activation leads to phosphorylation and that pathways utilized in TCR-and IL-2R-mediated signaling are activated as a result of lck overexpression.
of Shc in the Lck-Shc complex, followed by recruitment of Grb2-Sos by phosphorylated Shc to sites occupied by activated p56 lck at the cell membrane. The additional recruitment of Shc to phosphorylated CD3ζ observed following TCR engagement in mature lymphocytes may serve to amplify or sustain activation of the ras pathway in these cells (74) . It remains to be determined whether Sos is also present in the Shc-Lck complexes in normal thymocytes, as well as the molecular basis for this interaction. In addition, since the IL-2R is known to regulate p56 lck activity (11) and the Shc-Grb2 complex is proposed to mediate coupling of the IL-2R to Sos and p21 ras (47) , our data lend support for a model in which IL-2R-stimulated p21 ras activity is mediated via activation of p56 lck . p95 vav is the product of a proto-oncogene expressed exclusively in hematopoietic and trophoblast cells (50) . It contains a putative GNEF domain for small GTPases of the Rho/Rac family and a number of structural motifs shared by other signaling molecules (75) . That Vav may be involved in regulating cellular mitogenesis has been inferred from studies that document the transforming potential of mutant forms of phosphorylation (52) . Paradoxically, these findings have not been confirmed by other investigators who found no evidence confirm that elevated cAMP has an effect on post-translational modification of Raf-1 in thymocytes. Thus, forskolin treatment for Vav regulation of p21 ras in T cells activated by engagement of the IL-2R or CD28, or in fibroblasts transformed by Vav of the lck thymoblast lines converted the hyperphosphorylated form of Raf-1 into a faster-migrating, presumably inactive (47) . Regardless of the mechanism, a recent report shows that overexpression of p95 vav in Jurkat T cells leads to form. The biological consequence of this treatment is to inhibit G 1 /S transition and to induce PCD in lck-transformed activation of NFAT, a nuclear factor involved in regulating IL-2 gene expression (75) . We have demonstrated tyrosine thymoblasts. Intriguingly, at forskolin concentrations sufficient to induce these physiological alterations, the Erk2 kinase phosphorylation of p95 vav as a result of Lck overexpression, consistent with the observation that Vav can serve as a direct activity in LGF lines is reduced by only 50%. This observation, coupled with the limited extent of Erk2 activation demonstrable substrate for Lck in vitro (52) . Whether phosphorylation of Vav in lck thymoblast lines directly contributes to p21 ras regulation in LGY thymoblasts suggests the possibility that inhibition of molecules other than MAPK may be responsible for the or to NFAT activation awaits further investigation.
p21 ras couples TCR stimulation to MAPK activation and Raf-1 physiologic effects we have observed following forskolin treatment. This might reflect the ability of Raf-1 to act on other is proposed to be an effector molecule for p21 ras in T cells (47) . Our results show that Raf-1 is hyperphosphorylated in the lck substrates, such as IκB (82) . Alternatively, activated PKA may target molecules in addition to Raf-1. For example, it has thymoblast lines, suggesting the presence of activated forms of Raf-1 kinase. Similar observations have been made in bacubeen reported that PKA inhibits IL-2-dependent stimulation of p70 S6K by antagonizing phosphotidylinositol-3-kinase lovirus expression systems, where co-expression of Ras, Lck and Raf-1 results in fully activated Raf-1 kinase activity (64) .
activation (83). Our studies indicate that inhibition of phosphatidylinositol-3-kinase and p70 S6K also blocks G 1 /S cell-cycle However, unlike the findings in the baculovirus studies, we were unable to detect phosphorylation of Raf-1 on tyrosine residues transition in lck thymoblast lines; however, cell viability is not affected (K. Lin and K. Abraham, manuscript in preparation). in our cells (data not shown), perhaps reflecting the existence of abundant tyrosine phosphatase activities in thymocytes. Erk2
Thus, the cell-cycle blockade induced by forskolin may reflect combined inhibitory effects of PKA on both Raf-1 and phoskinase activity is elevated Ͼ20-fold in thymoblast lines expressing the activated/mutant form of Lck (p56F505), phatidylinositol-3-kinase-p70 S6K pathways; however, the unique ability of forskolin to induce PCD must be independent whereas Ͻ2-fold activation is detected in thymoblast lines overexpressing wild-type Lck, despite the presence of slowerof its effect on the latter pathway. Taken together, our observations suggest that activation of migrating forms of Raf-1 in both cases. Similar results have been documented in studies of IL-2R-mediated signal transthe Lck kinase in immature thymocytes is sufficient to induce tyrosine phosphorylation and activation of components of duction, where there are discrepant reports as to whether IL-2-mediated stimulation of Erk2 occurs, although IL-2R triggering the Ras/Raf/MAPK pathway normally associated with T cell activation mediated via the TCR and IL-2R. The ability of is associated with p21 ras and Raf-1 activation (77,78). The basis for this discrepancy may lie in recent data which indicates that p56 lck to promote tumorigenesis in developing thymocytes presumably reflects the role of this molecule in controlling cell phosphatase activity may limit Erk2 stimulation (47, 79) . Indeed, treatment of lck thymoblast lines with the tyrosine phoscell replication, and underscores the possible importance of p56 lck in regulating TCR-and IL-2R-stimulated cell-cycle phatase inhibitor pervanadate rapidly converted proportions of Erk1 and Erk2 into slower-migrating, hyperphosphorylated transition. It should be noted that the ability of Lck to both promote tumorigenesis and suppress V β gene rearrangement forms, strongly suggesting counterbalancing of MAPK activation by phosphatase activities in thymocytes. That the activis dependent on p56 lck kinase activity. Whether some or all of the same signaling pathways are utilized by Lck to exert ated/mutant form of Lck appears to be more potent in stimulating MAPK activity than the wild-type kinase may imply the two biological effects is currently under investigation. that negative regulators acting on tyrosine 505, such as the Csk kinase (80) 
